Form4insider filings, from the source

Insider · CIK 0001326969

Camille L Bedrosian

Files at: AMLX, CRNX, RARE. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $325k · 1net −$325k
$10k$10k$100k$100k$1M$1MbuyssalesSep 9Sep 9Sep 9Sep 10Sep 10Sep 10Sep 11

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Sep 10, 2026 SForm 4 →Sep 14, 4:00 pm EDTAmylyx Pharmaceuticals, Inc.AMLX10,028$32.40$324,868278,064−3.48%
Sep 1, 2026 DForm 4 →Sep 1, 5:00 pm EDTCrinetics Pharmaceuticals, Inc.CRNX22,225$85.00$1,889,1250—
Aug 18, 2026 AForm 4 →Aug 20, 9:00 pm EDTAmylyx Pharmaceuticals, Inc.AMLX22,807——288,092—
Jun 18, 2026 AForm 4 →Jun 22, 5:02 pm EDTCrinetics Pharmaceuticals, Inc.CRNX5,925——22,225—
Mar 1, 2019 AForm 4 →Mar 4, 5:09 pm ESTUltragenyx Pharmaceutical Inc.RARE7,000——23,364— plan?
Jan 30, 2019 FForm 4 →Feb 15, 5:49 pm ESTUltragenyx Pharmaceutical Inc.RARE1,636$48.85$79,91916,364— plan? late
Jan 30, 2018 AForm 4 →Jan 31, 6:39 pm ESTUltragenyx Pharmaceutical Inc.RARE18,000——18,000— plan?

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Sep 1, 2026 DForm 4 →Sep 1, 5:00 pm EDTCrinetics Pharmaceuticals, Inc.CRNX110,080$60.71$6,682,5940—
Jun 18, 2026 AForm 4 →Jun 22, 5:02 pm EDTCrinetics Pharmaceuticals, Inc.CRNX9,730——9,730—
Mar 1, 2019 AForm 4 →Mar 4, 5:09 pm ESTUltragenyx Pharmaceutical Inc.RARE21,500——21,500—
Jan 30, 2018 AForm 4 →Jan 31, 6:39 pm ESTUltragenyx Pharmaceutical Inc.RARE88,000——88,000—